SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: (Date of earliest event reported) March 5, 2003
Gish Biomedical, Inc.
----------------------------------------------------------
(Exact name of registrant as specified in its charter)
California
--------------------------------------------------
(State or other jurisdiction of Incorporation)
0-10728 95-3046028
------------- -----------------
(Commission File Number) (IRS Employer Identification Number)
22942 Arroyo Vista, Rancho Santa Margarita, California 92688
--------------------------------------------------------------
(Address of Principal Executive Offices, Zip Code)
949-635-6200
---------------------------------------------------
(Registrant's Telephone Number, including area code)
Not Applicable
---------------------------------------
(Former name of former addresses, if changed since last report)
Item 5. Other Events
On March 6, 2003 CardioTech International, Inc., issued a press release
announcing that at special meetings held on March 5, 2003 the shareholders of
CardioTech International, Inc., and Gish Biomedical, Inc., approved proposals to
effect the merger of the two companies.
A copy of the press release is attached hereto as Exhibit 99 and
incorporated herein in its entirety by this reference.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Gish Biomedical, Inc.
March 10, 2003 /s/ John W. Galuchie, Jr.
----------------------------
John W. Galuchie, Jr.
Chairman